Search

Search Constraints

You searched for: Author/Creator Tran, Albert

Search Results

1. 12 Weeks of a Ribavirin‐Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver Transplantation. Issue 4 (5th October 2018)

2. 821Daclatasvir and Asunaprevir Plus Peginterferon Alfa-2a and Ribavirin in Patients With HCV Genotype 1 or 4 Infection: Phase 3 HALLMARK-QUAD Results. (December 2014)

3. ABO blood group does not influence Child‐Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts. (17th January 2022)

4. Assessment of D-Dimers for the Early Prediction of Complications in Acute Pancreatitis. Issue 7 (August 2016)

5. Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort). Issue 2 (28th October 2015)

6. Bax inhibitor‐1 protects from nonalcoholic steatohepatitis by limiting inositol‐requiring enzyme 1 alpha signaling in mice. Issue 2 (18th May 2018)

7. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Issue 10179 (6th April 2019)

8. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort). Issue 3 (20th March 2015)

9. Defects in mitophagy promote redox‐driven metabolic syndrome in the absence of TP53INP1. Issue 6 (31st March 2015)

10. Direct‐acting antiviral agent–based regimen for HCV recurrence after combined liver‐kidney transplantation: Results from the ANRS CO23 CUPILT study. Issue 11 (19th October 2017)